Next StepsGiven that LABS has so far exceeded in executing on their plans for the future and that they actually pulled off a large pharma partnership (as I really did hope they would), here is what I see for the near future:
1) Secure a Stada-like deal for NA. With obvious access to Bains, that might be easier now than one would think but a NA deal (primarily for the US) with a Tier 1 or 2 pharma would be wonderful
2) Get into the beverage market with a partnership with RedBull or Monster. You have to believe that those 'X-Games' type companies are licking their chops to find a way to engage their market with a CBD/THC based offering and LABS, with the credibilty it now has globally and their GMP manufacturing platform, offers an excellent partner with plenty of scale and regionalized production. Realize that this is a bit of a stretch and outside of the pharma business model, but this would be massive. May as well scoop the others before they get there....cause they will, especially if the US opens up.
3) Keep working with research entities and get the brand out there.
4) Get the damn SP up so we can list in the US. We have all this high horsepower on the Board, we need to use them! And when I mean get the SP up, I don't mean a reverse split.
In the end, LABS is doing exactly what they said they would, and have been executing flawlessly. They need to secure EU GMP quickly, to maintain the positive street cred and start moving to operational excellence to give the markets some peace.
While the price is bouncing around for a while, and while COVID didn't do us any favours, this company is an investment that will pay off large, sooner than one thinks.
IMO